Senectovia Medizinaltechnik AG has been acquired by a financial investor
In the context of succession in the ownership, a multi-family office has taken over Senectovia Medizinaltechnik AG. The owner of Senectovia has sold 100% of the shares and the two parties have agreed not to disclose the sale price.
Senectovia Medizinaltechnik AG is specialized in the distribution and maintenance of products for decubitus prophylaxis and therapy, patient mobility and obesity care. The product range includes medical mattresses and aids for patient positioning and mobilization. Thanks to the excellent service and high quality of its products, Senectovia has become the market leader in its core business in German-speaking Switzerland.
The buyer is a multi-family office that prefers to invest in mid-sized companies in healthcare and other industries. With this investor, Senectovia has gained a strong partner who will actively promote and further develop the company’s strategy and growth plans.
The previous owner, who has played a key role in shaping the company for over 20 years, will remain closely associated with Senectovia as a member of the Board of Directors, and will contribute his extensive industry experience to the management committee in order to provide the new investor with optimum support in implementing the initiated strategy.
Oaklins’ team in Switzerland supported the owner of Senectovia Medizinaltechnik AG during the entire sale process as exclusive M&A advisors. This included the preparation of the sale documents, the identification and approach of potential buyers, the supervision of the buy-side due diligence, as well as negotiations with several parties and support up to the signing and closing of the transaction.
Owner, Senectovia Medizinaltechnik AG
Talk to the deal team
Dr. Roberto Tracia
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
Agar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.Learn more
Cooper Consumer Health has sold Stardea to EA Pharma
Cooper Consumer Health has sold Stardea to EA Pharma.Learn more